Article Text

PDF

Athletes and fenoterol
  1. M K HENZE
  1. Deutsche Sporthochschule Köln
  2. 50933 Köln
  3. Germany
    1. P N R DEKHUIJZEN,
    2. H A MACHIELS,
    3. L M A HEUNKS,
    4. H F M VAN DER HEIJDEN,
    5. R H H VAN BALKOM
    1. Department of Pulmonary Diseases
    2. Academic Hospital Nijmegen
    3. P O Box 9101
    4. 6500 HB Nijmegen
    5. The Netherlands

      Statistics from Altmetric.com

      In a review of doping in athletes by Dr Dekhuijzen published recently in Thorax 1 the substance fenoterol was included in table 2 which listed respiratory drugs permitted by the International Olympic Committee (IOC). However, according to the IOC fenoterol is prohibited. Only salbutamol, salmeterol, and terbutaline are permitted by inhaler to prevent or treat asthma or exercise induced asthma. A written notification is necessary.

      Table 2

      Respiratory drugs permitted by the IOC (shortened and adapted from IOC1)

      To prevent positive doping cases caused by misinformation of athletes and their advisors which might cause questions of regress, it is necessary to print a correction.

      References

      authors' reply We thank Dr Henze for this correction. As in the case of formoterol, there is no scientific reasoning given by the IOC for fenoterol not to be permitted by inhalation, in contrast to salbutamol, terbutaline, and salmeterol. There are no specific pharmacological or pharmacodynamic characteristics of inhaled fenoterol or formoterol that would predict a relevant stimulating effect on the respiratory system. For clarity we reproduce here the correct list of permitted respiratory drugs.

      References

      1. 1-1.
      View Abstract

      Request permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.